Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab

Hiroki Yamada, Yuko Kaneko, Hiroya Tamai, Tsutomu Takeuchi

研究成果: Letter › 査読

本文言語	English
ページ（範囲）	440-442
ページ数	3
ジャーナル	Rheumatology (United Kingdom)
巻	59
号	2
DOI	https://doi.org/10.1093/rheumatology/kez284
出版ステータス	Published - 2020

ASJC Scopus subject areas

@article{03963bcec57a422fb2f3c0fb90ed475e,

title = "Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab",

author = "Hiroki Yamada and Yuko Kaneko and Hiroya Tamai and Tsutomu Takeuchi",

year = "2020",

doi = "10.1093/rheumatology/kez284",

language = "English",

volume = "59",

pages = "440--442",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab

AU - Yamada, Hiroki

AU - Kaneko, Yuko

AU - Tamai, Hiroya

AU - Takeuchi, Tsutomu

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85078551393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078551393&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kez284

DO - 10.1093/rheumatology/kez284

M3 - Letter

C2 - 31504968

AN - SCOPUS:85078551393

SN - 1462-0324

VL - 59

SP - 440

EP - 442

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 2

ER -